BMRA
Income statement / Annual
Last year (2025), Biomerica, Inc.'s total revenue was $5.31 M,
a decrease of 1.92% from the previous year.
In 2025, Biomerica, Inc.'s net income was -$4.97 M.
See Biomerica, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
05/31/2025 |
05/31/2024 |
05/31/2023 |
05/31/2022 |
05/31/2021 |
05/31/2020 |
05/31/2019 |
05/31/2018 |
05/31/2017 |
05/31/2016 |
| Operating Revenue |
$5.31 M |
$5.42 M |
$5.34 M |
$18.87 M |
$7.20 M |
$6.69 M |
$5.20 M |
$5.56 M |
$5.79 M |
$5.14 M |
| Cost of Revenue |
$4.81 M
|
$4.80 M
|
$4.89 M
|
$15.89 M
|
$6.83 M
|
$4.91 M
|
$3.91 M
|
$3.81 M
|
$3.77 M
|
$3.62 M
|
| Gross Profit |
$498.00 K
|
$611.00 K
|
$446.00 K
|
$2.98 M
|
$366.29 K
|
$1.78 M
|
$1.29 M
|
$1.75 M
|
$2.02 M
|
$1.52 M
|
| Gross Profit Ratio |
0.09
|
0.11
|
0.08
|
0.16
|
0.05
|
0.27
|
0.25
|
0.32
|
0.35
|
0.3
|
| Research and Development Expenses |
$1.02 M
|
$1.49 M
|
$1.58 M
|
$1.81 M
|
$2.19 M
|
$1.91 M
|
$1.68 M
|
$1.40 M
|
$1.13 M
|
$780.33 K
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$14.61 K
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.22 K
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.61 M
|
$5.49 M
|
$6.09 M
|
$5.70 M
|
$5.67 M
|
$2.27 M
|
$2.03 M
|
$1.84 M
|
$1.85 M
|
$1.57 M
|
| Other Expenses |
$0.00
|
$0.00
|
$1.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.01 K
|
| Operating Expenses |
$5.64 M
|
$6.98 M
|
$7.67 M
|
$7.51 M
|
$7.87 M
|
$4.18 M
|
$3.70 M
|
$3.24 M
|
$2.98 M
|
$2.35 M
|
| Cost And Expenses |
$10.45 M
|
$11.78 M
|
$12.56 M
|
$23.41 M
|
$14.70 M
|
$9.10 M
|
$7.61 M
|
$7.05 M
|
$6.75 M
|
$5.97 M
|
| Interest Income |
$165.00 K
|
$431.00 K
|
$133.00 K
|
$27.00 K
|
$66.86 K
|
$71.19 K
|
$44.01 K
|
$47.76 K
|
$46.35 K
|
$24.12 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$367.00
|
$9.00
|
$47.00
|
$37.00
|
$282.00
|
$167.00
|
| Depreciation & Amortization |
$400.00 K
|
$374.00 K
|
$351.00 K
|
$594.82 K
|
$375.86 K
|
$398.63 K
|
$162.91 K
|
$186.60 K
|
$219.22 K
|
$232.42 K
|
| EBITDA |
-$4.74 M |
-$5.99 M |
-$6.87 M |
-$3.94 M |
-$7.06 M |
-$1.93 M |
-$2.21 M |
-$1.25 M |
-$689.34 K |
-$563.57 K |
| EBITDA Ratio |
-0.89
|
-1.11
|
-1.29
|
-0.21
|
-0.98
|
-0.29
|
-0.42
|
-0.22
|
-0.12
|
-0.11
|
| Operating Income Ratio |
-0.97
|
-1.18
|
-1.35
|
-0.24
|
-1.04
|
-0.36
|
-0.46
|
-0.27
|
-0.16
|
-0.16
|
| Total Other Income/Expenses Net |
$165.00 K
|
$431.00 K
|
$134.00 K
|
$26.64 K
|
$66.50 K
|
$71.18 K
|
$43.97 K
|
$47.73 K
|
$46.07 K
|
$30.97 K
|
| Income Before Tax |
-$4.97 M
|
-$5.94 M
|
-$7.09 M
|
-$4.51 M
|
-$7.43 M
|
-$2.33 M
|
-$2.37 M
|
-$1.43 M
|
-$908.56 K
|
-$795.99 K
|
| Income Before Tax Ratio |
-0.94
|
-1.1
|
-1.33
|
-0.24
|
-1.03
|
-0.35
|
-0.46
|
-0.26
|
-0.16
|
-0.15
|
| Income Tax Expense |
$1.00 K
|
$42.00 K
|
$51.00 K
|
$23.72 K
|
$13.06 K
|
$7.39 K
|
$24.24 K
|
$31.80 K
|
$0.00
|
$703.80 K
|
| Net Income |
-$4.97 M
|
-$5.98 M
|
-$7.14 M
|
-$4.53 M
|
-$7.45 M
|
-$2.34 M
|
-$2.39 M
|
-$1.47 M
|
-$908.56 K
|
-$1.50 M
|
| Net Income Ratio |
-0.94
|
-1.1
|
-1.34
|
-0.24
|
-1.03
|
-0.35
|
-0.46
|
-0.26
|
-0.16
|
-0.29
|
| EPS |
-2.16 |
-0.36 |
-0.5 |
-0.36 |
-0.54 |
-0.23 |
-0.26 |
-0.17 |
-0.11 |
-0.2 |
| EPS Diluted |
-2.16 |
-0.36 |
-0.5 |
-0.36 |
-0.54 |
-0.23 |
-0.26 |
-0.17 |
-0.11 |
-0.2 |
| Weighted Average Shares Out |
$2.30 M
|
$16.82 M
|
$14.15 M
|
$12.67 M
|
$11.93 M
|
$10.17 M
|
$9.21 M
|
$8.57 M
|
$8.26 M
|
$7.50 M
|
| Weighted Average Shares Out Diluted |
$2.30 M
|
$16.82 M
|
$14.15 M
|
$12.67 M
|
$11.93 M
|
$10.17 M
|
$9.21 M
|
$8.57 M
|
$8.33 M
|
$7.63 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
